1st Quarter - Report

EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC

Firm
Client
Income
—
Expenses
$900,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding Substance Abuse and Mental Health Block Grant (SABG) funding National Defense Authorization Act for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone

LobbyistCovered position, as disclosed
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE; Health & Human Services, Dept of (HHS)

Disaster Planning/Emergencies DIS

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding Substance Abuse and Mental Health Block Grant (SABG) funding National Defense Authorization Act for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone

LobbyistCovered position, as disclosed
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: White House Office; SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding Substance Abuse and Mental Health Block Grant (SABG) funding National Defense Authorization Act for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone

LobbyistCovered position, as disclosed
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS)

Health Issues HCR

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding Substance Abuse and Mental Health Block Grant (SABG) funding National Defense Authorization Act for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone

LobbyistCovered position, as disclosed
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.